Participants 69 101 3
patients with myasthenia gravis.
Participants 111 194 3
Patients with myasthenia gravis receive pyridostigmine, an anticholinesterase agent
Participants 713 868 4
Medically (oral pyridostigmine) well-controlled adult patients with myasthenia gravis who were posted for thymectomy, were randomly divided into two groups
Participants 1286 1372 3
Fourteen patients (7 in each group) belonging to both sexes were enrolled in the study
